Building the global vaccine manufacturing capacity needed to respond to pandemics
Vaccine
.
2021 Mar 19;39(12):1667-1669.
doi: 10.1016/j.vaccine.2021.02.017.
Epub 2021 Feb 24.
Authors
Tara Kirk Sell
1
,
Daniel Gastfriend
1
,
Matthew Watson
1
,
Crystal Watson
1
,
Lauren Richardson
1
,
Anita Cicero
1
,
Tom Inglesby
1
,
Nancy Connell
1
Affiliation
1
Johns Hopkins Center for Health Security, Johns Hopkins Bloomberg School of Public Health, United States.
PMID:
33640143
PMCID:
PMC7903906
DOI:
10.1016/j.vaccine.2021.02.017
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Capacity Building
Global Health
Humans
Influenza Vaccines*
Influenza, Human* / epidemiology
Influenza, Human* / prevention & control
Pandemics / prevention & control
Substances
Influenza Vaccines